Needy Patients Suffering Due to Uneven Access to Painkillers, Pharmacist Survey Finds

Published Online: Thursday, January 9, 2014
Follow Pharmacy_Times:

ALEXANDRIA, Va. (Jan. 9, 2014) – Some of society’s most vulnerable patients, including seniors and those battling cancer, face a significant struggle to obtain medications prescribed to alleviate crippling pain, according to a survey of 1,000-plus community pharmacists conducted by the National Community Pharmacists Association (NCPA). In addition, surprise disruptions in an unpredictable supply chain make it impossible for many community pharmacists to assure patients that their prescription for these controlled substances can be filled the following month, the survey found.

“Vulnerable patients are increasingly and tragically becoming collateral damage in the country’s battle against the abuse of prescription drugs, particularly narcotic painkillers,” said NCPA CEO B. Douglas Hoey, RPh, MBA. “In the survey, community pharmacists repeatedly cited having their supplies or shipments of controlled substances abruptly shut off by their wholesalers, which may have done so due to perceived pressure, intimidation or a lack of clear guidance from law enforcement officials, such as the Drug Enforcement Administration (DEA).”

Key points from the survey include:
  • Approximately 75% of respondents experienced three or more delays or issues caused by stopped shipments with their controlled substance orders, over the past 18 months.
  • On average, 55 patients-per-pharmacy were impacted by these delays.
  • 89% of impacted pharmacies received no advanced notice of the delay; they only found out when their order arrived and included just non-controlled substances.
  • 60% said the delays in receiving these requested medications lasted at least one week.
  • 67.9% were unable to procure controlled substances from an alternate source, such as a secondary wholesaler.
  • Most reported having to turning patients away and referring them to a local competitor.
The survey included an open-ended section in which community pharmacists shared hundreds of observations, including the following:
  • “It is a shame to watch an arthritic 85-year-old do without.”
  • “This situation has literally brought customers to tears in our store. I fully understand the diversion and abuse of these powerful chemicals. I agree that something must be done, but to deny pain management to deserving individuals is inhumane at best. We have to find a way to curb the abuse and still provide relief from pain for those truly suffering.”
  • “We turn away patients on a daily basis that I am sure are legitimate patients with legitimate prescriptions with legitimate issues requiring pain management. I am one in a long line of pharmacies that turns these patients away because of the limits on what I can dispense monthly.”
  • “A few cancer and pain patients who really need their meds went without it for a few days. Has happened too many times.”
  • “We try to scrutinize all controlled substance prescriptions, but are made to feel like criminals when trying to service our patients.”
In presentations to Congress and to the Food and Drug Administration and DEA, NCPA has recommended steps to combat prescription drug abuse, while protecting patients. They include electronic prescription drug monitoring programs and tracking systems, more effective education of prescribers, shutting down rogue pain clinics, offering more disposal options for excess medications and more scrutiny of controlled substances delivered by mail order pharmacies.
Related Articles
A diverse collective of health care advocacy groups, patient organizations, industry representatives and other stakeholders today announced they have established the Alliance for Balanced Pain Management to support appropriate access to integrated pain management and responsible use of prescription pain medicines with an aim to reduce abuse. AfBPM will work collaboratively to educate, support and advocate on behalf of people affected by pain, both acute and chronic.
Cocaine users complaining of chest pain may have abnormal blood flow in the heart’s smallest blood vessels that may not be detected in regular testing, putting these patients at risk for heart complications or death, according to research presented at the American Heart Association’s Scientific Sessions 2014.
While some pharmacies have their drugs stolen by robbers, a pharmacy in Tampa, Florida, had its drugs taken by the Drug Enforcement Administration.
Blood testing will soon be painless, quick, accurate, and inexpensive, and patients won’t need to go to a lab or doctor’s office.
Latest Issues